|
Press and Media
Join us at Asia Antibody Congress 2008 for months of highly targeted exposure. Capitalise on this ideal platform to market your publication and form strategic relationships through networking at Asia Antibody Congress 2008!!
-
Brand your publication with an event that the industry believes in
-
Fully capitalise on our integrated marketing campaign
-
Increased customer contact and business opportunities
-
Wider exposure to International organisations
-
A unique opportunity to give clients “hands on” experience with your products / services
-
Gain exclusive interviews with the region’s movers and shakers
-
Avail yourself of invaluable editorial & feature content at the conference
For more information on how your title can be profiled as the industry's leading publication, please contact:
Juliana Tyan
Marketing Manager
Email: juliana.tyan@terrapinn.com
Tel: +65 6322 2726
Fax: +65 6226 3264
BioPharm International integrates the science and business of biopharmaceutical research and development, and production/manufacturing. The magazine provides peer-reviewed technical solutions to enable biopharmaceutical R&D, manufacturing, process, lab, clinical, engineering and business professionals to confront work challenges.
BioPharm International is the longest-running peer-reviewed publication serving an audited global audience of 29,245 BPA-qualified professionals involved in the development and manufacturing of therapeutics and management of related business issues. With the largest US readership in the biopharmaceutical market, BioPharm reaches a large universe of leading biotech and pharmaceutical companies, giving solution providers direct access to the core purchasing power of the biopharmaceutical industry.
BioSpectrum Asia is a unique, integrated B2B media platform of print, digital, online and events. It engages its readers from Life-Sciences industry (Pharma, Biotech & Medtech) across Asia pacific region on a Daily/Fortnightly/Monthly through its media products and services.
BioSpectrum Asia started, as first Business life-science industry magazine with an objective to create a platform for growing Asia-pacific life sciences industry and is today the largest distributed Pan-Asia Life-Sciences industry magazine. The magazine is published, printed and distributed from Singapore by Cyber Media (Singapore) Pte Limited.
General Biologic is information, research, and advisory firm focused on China's pharmaceutical, biotechnology and healthcare industries. Based in Shanghai, GB helps companies and investors understand and act on opportunities in China. GB is the publisher of China Pharmaceutical & Biotechnology Monthly, industry reports, databases, and audio interviews with leaders in China's healthcare industry.
GB provides management consulting and transaction services to clients in aspects of solving difficult strategic and capital allocation issues. The main focus areas of GB’s consulting services for new-entries investors in China include market research; strategy development; valuation and due diligence; partner screening and management. GB’s strong local networks are critical to accessing quality investment and licensing opportunities. We provide unparalleled access in main areas like providing investment opportunities to private equity and venture capital clients and evaluating technologies for licensing.
|
